The Modern Toolkit: Treatment Standards and Options

Treating migraine has changed dramatically in recent years. For a long time, the medications used to prevent migraines were “repurposed” drugs originally designed for epilepsy, high blood pressure, or depression. While these can still be effective, we now have treatments designed specifically for the biological pathways of migraine ^[1][2].

A New Standard of Care: The 2024 Updates

In 2024, the American Headache Society (AHS) released a landmark update to its consensus statement. The most significant change is that CGRP-targeting therapies are now officially recommended as a first-line treatment for migraine prevention ^[1].

Previously, many doctors required patients to “fail” older medications before accessing newer ones. The AHS now states that because the evidence for the safety and effectiveness of CGRP-targeted therapies exceeds older options, they should be offered as a primary choice ^[1][2]. These first-line options include:

• Monoclonal Antibodies (mAbs): Injectable or IV treatments like erenumab, fremanezumab, galcanezumab, and eptinezumab ^[1].
• Gepants: Oral pills like rimegepant and atogepant ^[1].

Important Insurance Note: While the medical guidelines empower you to ask for these first-line treatments, be prepared for administrative hurdles. Insurance companies frequently impose step therapy (forcing you to try older drugs first) or require prior authorizations. Ask your clinic about manufacturer savings cards to help bypass some of these costs while appealing insurance denials.

Acute vs. Preventive Treatment

Your treatment plan will likely involve two different types of tools:

1. Acute (Abortive) Treatment: Taken to stop an attack that has already started.
   • Triptans: The traditional gold standard ^[3]. Timing matters: Triptans are most effective when taken as soon as the pain begins, not during the aura phase.
   • Gepants: A newer alternative. They often provide “sustained relief” (pain not coming back for 24 hours) and are safer for people with cardiovascular issues like heart disease ^[4][5].
2. Preventive Treatment: Taken regularly (daily or monthly) to reduce the total number of attacks. To know if a preventive is working, you typically need an adequate trial period of at least 2 to 3 months at the target dose ^[6][7].

Non-Pharmacological and Neuromodulation Options

Medicine isn’t the only tool available.

• At-Home Relief: Many patients find relief through ice caps, resting in a dark/quiet room, hydration, and green light therapy.
• Devices: FDA-cleared neuromodulation devices (like Cefaly or Nerivio) stimulate specific nerves to block pain pathways. These are excellent options for patients who prefer to avoid medications or cannot tolerate side effects.

The Danger of Over-Treating: Medication-Overuse Headache (MOH)

Taking acute medications too frequently—usually more than 10 to 15 days per month—can cause the brain to become more sensitive, leading to Medication-Overuse Headache (MOH) ^[8]. Historically, fixing MOH required a difficult “detox” period. However, recent research shows that starting a CGRP-targeted preventive medication can reverse MOH without requiring a withdrawal period ^[9][10].

Pregnancy and Family Planning

Because migraine disproportionately affects women of childbearing age, family planning is critical. Many migraine medications (including traditional preventives and newer CGRP therapies) are either unsafe or have unknown safety profiles during pregnancy and breastfeeding. Always discuss your family planning goals with your neurologist before starting or stopping any treatment.